Abstract
Background
The prognostic value of cardiac troponins (cTn) in patients with non‐ST‐segment elevation acute coronary syndromes (NSTE ACS) and chronic kidney disease (CKD) is debated.
Hypothesis
We tested the performance of cTnI and cTnT for risk stratification in patients with CKD and evaluated the prognostic significance of cTnI and cTnT elevations by their magnitude across the range of CKD severity.
Methods
We examined correlations among cTn elevation, CKD, and in‐hospital mortality in 31,586 high‐risk patients with NSTE ACS included in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines initiative (CRUSADE). Cardiac tropinins I and T levels were categorized as ratios of each site's upper limit of normal (ULN) for myocardial necrosis: normal (cTn ratio ⩽1 × ULN), mild (cTn ratio > 1–3 × ULN), and major (cTn ratio > 3 × ULN) elevation. Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in Renal Disease equation. Stages of CKD were categorized as normal to mild (eGFR > 60 mL/min), moderate (eGFR 30–60 mL/min), or severe (eGFR < 30 mL/min).
Results
Mortality increased more steeply across CKD stages (2.0%–12.9%) than across cTn ratio categories (2.7%–5.4%). In normal or mild CKD, mortality was low regardless of cTn elevations. In moderate CKD, mortality increased incrementally with cTnI (3.3% versus 5.4% versus 7.4%) and cTnT (3.7% versus 5.3% versus 7.3%) elevation. Among severe CKD patients, only major cTn elevations further distinguished risk (cTnI: 10.1% versus 9.7% versus 14.6%; cTnT: 7.0% versus 5.7% versus 14.0%).
Conclusions
In patients with CKD, cTnI and cTnT perform equally in differentiating short‐term prognosis following NSTE ACS; however, the prognostic impact of cTn is dependent upon the degree of CKD severity. Copyright © 2008 Wiley Periodicals, Inc.
Keywords: cardiac troponins, non‐ST‐segment, elevation acute coronary syndromes, chronic kidney disease, prognostic indicators
Full Text
The Full Text of this article is available as a PDF (188.0 KB).
References
- 1. Newby LK, Goldmann BU, Ohman EM: Troponin: an important prognostic marker and risk‐stratification tool in non‐ST‐segment elevation acute coronary syndromes. J Am Coll Cardiol 2003; 41: S31–S36. [DOI] [PubMed] [Google Scholar]
- 2. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, et al.: GUSTO‐IIb, GUSTO‐III, PURSUIT. Global use of strategies to open occluded coronary arteries. Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy; PARAGON‐A investigators. Platelet IIb/IIIa antagonism for the reduction of acute coronary syndrome events in a global organization network. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106(8): 974–980. [DOI] [PubMed] [Google Scholar]
- 3. Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, et al., TIMI Study Group: Association of glomerular filtration rate on presentation with subsequent mortality in non‐ST‐segment elevation acute coronary syndrome; observations in 13,307 patients in 5 TIMI trials. Eur Heart J 2004; 25(22): 1998–2005. [DOI] [PubMed] [Google Scholar]
- 4. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, et al.: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351(13): 1285–1295. [DOI] [PubMed] [Google Scholar]
- 5. McLaurin MD, Apple FS, Voss EM, Herzog CA, Sharkey SW: Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 1997; 43(6 Pt. 1): 976–982. [PubMed] [Google Scholar]
- 6. Freda BJ, Tang WH, Van Lente F, Peacock WF, Francis GS: Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002; 40: 2065–2071. [DOI] [PubMed] [Google Scholar]
- 7. Hamm CW, Giannitsis E, Katus HA: Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002; 106(23): 2871–2872. [DOI] [PubMed] [Google Scholar]
- 8. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, et al.: Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002; 346(26): 2047–2052. [DOI] [PubMed] [Google Scholar]
- 9. Hoekstra JW, Pollack CV Jr, Roe MT, Peterson ED, Brindis R, et al.: Improving the care of patients with non‐ST‐elevation acute coronary syndromes in the emergency department: the CRUSADE Initiative. Acad Emerg Med 2002; 9(11): 1146–1155. [DOI] [PubMed] [Google Scholar]
- 10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al.: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130(6): 461–470. [DOI] [PubMed] [Google Scholar]
- 11. Am J Kidney Dis Executive summary: K/DOQI clinical practice guidelines. 2002; 39: S17–S31. [Google Scholar]
- 12. Roe MT, Peterson ED, Li Y, Pollack CV Jr, Christenson RH, et al.: Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non‐ST‐segment elevation acute coronary syndromes. Arch Intern Med 2005; 165(16): 1870–1876. [DOI] [PubMed] [Google Scholar]
- 13. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13–22. [Google Scholar]
- 14. Apple FS, Sharkey SW, Hoeft P, Skeate R, Voss E, et al.: Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A 1‐year outcomes analysis. Am J Kidney Dis 1997; 29(3): 399–403. [DOI] [PubMed] [Google Scholar]
- 15. Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, et al.: Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case‐matched study. J Am Coll Cardiol 1999; 33(2): 471–478. [DOI] [PubMed] [Google Scholar]
- 16. McLaurin MD, Apple FS, Falahati A, Murakami MM, Miller EA, et al.: Cardiac troponin I and creatine kinase‐MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency. Am J Cardiol 1998; 82(8): 973–975. [DOI] [PubMed] [Google Scholar]
- 17. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PA, et al.: Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false‐positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998; 44(9): 1919–1924. [PubMed] [Google Scholar]
- 18. Apple FS, Murakami MM, Pearce LA, Herzog CA: Predictive value of cardiac troponin I and T for subsequent death in end‐stage renal disease. Circulation 2002; 106(23): 2941–2945. [DOI] [PubMed] [Google Scholar]